RetinalGenix Technologies (RTGN) Notes Payables (2022 - 2026)
RetinalGenix Technologies recorded quarterly Notes Payables of $49000.0 in Q1 2026, little changed quarter-over-quarter from $49000.0 in Q4 2025.
RetinalGenix Technologies' Notes Payables history runs 4 years deep, the most recent figure standing at $49000.0 for Q1 2026.
- In Q1 2026, Notes Payables changed N/A year-over-year to $49000.0; the TTM figure through Mar 2026 stood at $49000.0 (changed N/A YoY), while the FY2025 annual figure was $49000.0, changed N/A from the prior year.
- Notes Payables came in at $49000.0 for Q1 2026 at RetinalGenix Technologies, roughly flat from $49000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $49000.0 in Q4 2022 to a low of $49000.0 in Q4 2022.
- A 4-year average of $49000.0 and a median of $49000.0 in 2022 frame the typical range for Notes Payables.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RetinalGenix Technologies | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49,000.00 |
| Dec 31, 2025 | 49,000.00 |
| Sep 30, 2023 | 49,000.00 |
| Dec 31, 2022 | 49,000.00 |